FLASCO

Legislative Actions

Home » Advocacy » Legislative Actions
COA

300+ National & State Organizations Ask Congress: Stop the CMS Drug Payment Proposal!

This morning an unprecedented 313 national and state health care organizations, including FLASCO sent a letter to Congress expressing strong concern with the proposed CMS Medicare Part B Drug Payment Model. The organizations request that Congress ask CMS to withdraw the proposed rule. Click here to read the latest letter. The letter notes that the organizations believe…

0 comments
FMA

2016 FMA Legislative Report

During the 2016 Florida Legislative Session, which ended on Friday, March 11, the FMA kept close watch on 211 bills and a host of amendments that would have affected you and your patients. Of the total 1,638 bills and proposed constitutional amendments filed for the 60-day session, the Legislature passed 272 and has sent them…

0 comments
bristol-myers-logo

FDA approves Bristol Myers- Squibb’s Opdivo to treat Advanced Form of Kidney Cancer

On November 23, 2015, the U. S. Food and Drug Administration approved nivolumab (Opdivo Injection, Bristol-Myers Squibb Company) for the treatment of advanced renal cell carcinoma in patients who have received prior anti-angiogenic therapy. The approval was based on a randomized study in which patients with advanced renal cell cancer who had received prior anti-angiogenic…

0 comments
The US Oncology Network

Bipartisan Lawmakers Send Letters to CMS Opposing Proposed Cuts to Radiation Therapy

Bipartisan Lawmakers Send Letters to CMS Opposing Proposed Cuts to Radiation Therapy (Source:  US Oncology) This week 228 bipartisan lawmakers in Congress sent three letters to the Centers for Medicare & Medicaid Services (CMS) asking the agency to reconsider proposed cuts to radiation oncology recommended in its 2016 Physician Fee Schedule (PFS) Proposed Rule. In…

0 comments
Medicare Part D

Part D Beneficiary Appeals Fairness Act!

Medicare Part D is supposed to help seniors manage the cost of their prescriptions. But too many of the most vulnerable seniors on Medicare – those with life-threatening conditions like cancer, HIV/AIDS, rheumatoid arthritis, and multiple sclerosis – are facing extreme co-pays because their medication falls onto a “specialty tier.” The Part D Beneficiary Appeals…

0 comments
The US Oncology Network

Join the Effort to Stop Medicare Cuts to Radiation Oncology

Join the Effort to Stop Medicare Cuts to Radiation Oncology  Contact Your Members of Congress Today! In its 2016 Physician Fee Schedule Proposed Rule, CMS is proposing overall Medicare cuts of three percent to radiation oncology services, and an even deeper six percent Medicare cut to freestanding radiation therapy centers.   The proposed rule most…

0 comments
New-Drug-Was-Subsequently-Not-Approved

FLASCO Wants to Hear Your Step Therapy Story

FLASCO Wants To Hear Your Step Therapy Story FLASCO is working with other health care organizations to encourage Florida lawmakers to address the negative impact of Step Therapy policies. We are currently looking for stories about barriers and challenges to navigating Step Therapy and fail-first policies to share with the media. If you have any…

0 comments

 

Who’s Online

There are no users currently online